Dental Care Clinics in Enterprise, UT Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Enterprise Family Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 223 S 200 E, Enterprise, UT 84725 Phone: 435-878-2775 |
News Archive
Benzodiazepine drugs ineffective for PTSD and trauma treatment
Benzodiazepine drugs are widely used in patients with posttraumatic stress disorder (PTSD), but available evidence suggests that they are not effective-and may even be harmful, concludes a systematic review and meta-analysis in the July Journal of Psychiatric Practice.
Hypertension treatment could reduce hemorrhagic strokes by nearly 30 percent
Treating hypertension could cut the annual number of bleeding strokes in the United States by about one-fourth, according to a report in today's rapid access issue of Stroke: Journal of the American Heart Association.
U.S. District Court rules in favor of Cell Therapeutics to pursue all of its claims against The Lash Group
Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI's former third-party reimbursement consultant for CTI's product TRISENOX, in 2007 seeking $22.8 million in damages for expenses already incurred related to the investigation, defense and a settlement of claims by the U.S. government concerning Medicare reimbursement for TRISENOX and other business losses.
Aeterna Zentaris receives positive Scientific Advice from EMA for perifosine Phase 3 trial in colorectal cancer
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.
Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries
Opsens Inc. said today that its Medical Division has reached a significant milestone, successfully completing a pre-clinical animal study on the EasyWire device, designed to measure Fractional Flow Reserve in the evaluation of coronary lesions.
› Verified 8 days ago